Tumor Response and Survival Predicted by Post-Therapy FDG-PET/CT in Anal Cancer

A partial metabolic response in the anal tumor as determined by post-therapy FDG-PET is predictive of significantly decreased progression-free and cause-specific survival after chemoradiotherapy for anal cancer.